|Mike Berman, Venture Partner|
|Michael Berman, former president of Boston Scientificís Cardiovascular business, joined Israel Seed Partners as a Venture Partner and industry advisor in May 2004.
Berman is a medical device entrepreneur working with a select group of high potential development and early commercial stage companies. From 1995-2000 Mr. Berman was President of Boston Scientific/Scimed. As President of Scimed Mr. Berman expanded the Companyís leadership in the interventional cardiology market. Under his leadership, the company increased worldwide sales from $300 million to $1.5 billion, fully integrated four acquired interventional cardiology businesses, invested more than $250 million in research and technology, and introduced more than 40 new products. Prior to joining Scimed, Mr. Berman worked in marketing for Marietta Corporation from 1985-1986 and in Baxter Corporationís Israel facility from 1981-1984.
Berman holds several board seats and is currently also chairman of Topspin Medical and Ultrashape, two of Israel Seed Partnersí portfolio companies. He has a BA and an MBA from Cornell University.
The Israeli optical industry: Has the light faded?